Biomarkers of susceptibility following benzene exposure: Influence of genetic polymorphisms on benzene metabolism and health effects

Biomarkers in Medicine

Volumn 10, Issue 2, 2016, Pages 145-163

  Carbonari, Damiano ^a   Chiarella, Pieranna ^a   Mansi, Antonella ^a   Pigini, Daniela ^a   Iavicoli, Sergio ^a   Tranfo, Giovanna ^a  

^a Epidemiology and Hygiene ^*  (Italy)

Author keywords

Benzene; biomarker of exposure; biomarker of susceptibility; environment; genetic polymorphism; leukemia; occupational setting

Indexed keywords

BENZENE; BIOLOGICAL MARKER; CATALASE; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; HEME OXYGENASE 1; NQO1 PROTEIN; OXIDOREDUCTASE; PHENYLMERCAPTURIC ACID; SUPEROXIDE DISMUTASE; THIOREDOXIN; TRANS,TRANS MUCONIC ACID; UNCLASSIFIED DRUG; ACETYLCYSTEINE; GLUTATHIONE TRANSFERASE; MUCONIC ACID; POLLUTANT; S-PHENYL-N-ACETYLCYSTEINE; SORBIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; BIOTRANSFORMATION; CARCINOGENICITY; CHILDHOOD LEUKEMIA; CYP2E1 GENE; DNA REPAIR; ENVIRONMENTAL EXPOSURE; EPHX1 GENE; GENE; GENETIC POLYMORPHISM; GSTA1 1 GENE; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HUMAN; LONG TERM EXPOSURE; METABOLISM; MPO GENE; NQO1 GENE; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PH; REVIEW; TOXICITY; ADULT; ANALOGS AND DERIVATIVES; ANALYSIS; CARCINOGENESIS; CHEMICALLY INDUCED; CHILD; ENVIRONMENTAL MONITORING; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; POLLUTANT;

ACETYLCYSTEINE; ADULT; BENZENE; BIOMARKERS; BIOTRANSFORMATION; CARCINOGENESIS; CHILD; CYTOCHROME P-450 CYP2E1; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; SORBIC ACID;

EID: 84961315617     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.15.106     Document Type: Review

References (108)

1. Hoet P, De Smedt E, Ferrari M et al. Evaluation of urinary biomarkers of exposure to benzene: correlation with blood benzene and influence of confounding factors. Int. Arch. Occup. Environ. Health 82, 985-995 (2009).
2. IARC Chemical Agents and Related Occupations. Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer. A review of human carcinogens. Volume 100F (2012). http://monographs.iarc.fr
3. Carbonari D, Proietto AR, Fioretti M et al. Influence of genetic polymorphisms on t,t-MA/S-PMA ratio in 301 benzene exposed subjects. Tox. Lett. 231, 205-212 (2014).
4. Fustinoni S, Consonni D, Campo L et al. Monitoring low benzene exposure: comparative evaluation of urinary biomarkers, influence of cigarette smoking and genetic polymorphisms. Cancer Epidemiol. Biomarkers Prev. 14(9), 2237-2244 (2005).
5. Directive 2000/69/EC of The European Parliament and of The Council of 16 November 2000 relating to limit values for benzene and carbon monoxide in ambient air. EN Official Journal of the L 313/12 European Communities, 13.12.2000. www.irceline.be
6. Bolufer P, Barragan E, Collado M, Cervera J, López JA, Sanz M.A. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk. Res. 30 (12), 1471-1491 (2006).
7. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for Benzene. U.S. Department of Health and Human Services, Public Health Service, GA, USA (2007).
8. Wan JX, Zhang ZB, Guan JR et al. Genetic polymorphism of toxicant-metabolizing enzymes and prognosis of Chinese workers with chronic benzene poisoning. Ann. NY Acad. Sci. 1076, 129-136 (2006).
9. Snyder R. Xenobiotic metabolism and the mechanism(s) of benzene toxicity. Drug Metab. Rev. 36, 531-547 (2004).
10. Smith MT, Zhang L, McHale CM, Skibola CF, Rappaport SM. Benzene: the exposome and the future investigation of leukemia etiology. Chem. Biol. Interact. 192, 155-159 (2011).
11. McHale CM, Zhang L, Smith MT. Current understanding of the mechanism of benzene-induced leukemia in humans:implications for risk assessment. Carcinogenesis 33(2), 240-252 (2012).
12. Snyder R. Leukemia and benzene. Int. J. Environ. Res. Public Health 9, 2875-2893 (2012).
13. Arnold SM, Angerer J, Boogaard PJ et al. The use of biomonitoring data in exposure and human health risk assessment: benzene case study. Crit. Rev. Toxicol. 43(2), 119-153 (2013).
14. Wallace LA. Major source of benzene exposure. Environ. Health Perspect. 82, 165-169 (1989).
15. Wallace LA. Environmental exposure to benzene: an update. Environ. Health Perspect. 104, 1129-1136 (1996).
16. Johnson ES, Langard S, Lin YS. A critique of benzene exposure in general population. Sci. Total Environ. 374, 183-198 (2007).
17. NASA 1990-1999. Spacecraft maximum allowable concentration. NASA Johnston Space Center Houston Texas. www.cdc.gov
18. Fleming-Jones ME, Smith RE. Volatile organic compounds in foods: a five year study. J. Agric. Food Chem. 51, 8120-8127 (2003).
19. Carrieri M, Bonfiglio E, Scapellato ML et al. Comparison of exposure assessment methods in occupational exposure to benzene in gasoline filling-station attendants. Tox. Lett. 162(2-3), 146-152 (2006).
20. Capleton AC, Levy LS. An overview of occupational benzene exposures and occupational exposure limits in Europe and North America. Chem. Biol. Interact. 153-154, 43-53 (2005).
21. Kirkeleit J, Riise T, Bråtveit M, Pekari K, Mikkola J, Moen BE. Biological monitoring of benzene exposure during maintenance work in crude oil cargo tanks. Chem. Biol. Interact. 164(1-2), 60-67 (2006).
22. Manini P, De Palma G, Andreoli R et al. Environmental and biological monitoring of benzene exposure in a cohort of Italian taxi drivers. Tox. Lett. 167(2), 142-151 (2006).
23. Directive 98/70/EC of the European Parliament and of the Council of 13 October 1998 relating to the quality of petrol and diesel fuels and amending Council Directive 93/12/EEC. EN Official Journal L350 European Communities, 28/12/1998 pp. 0058-0068. 24 Directive 97/42/EC of 27 June 1997 amending for the first time Directive 90/394/EEC on the protection of workers from the risks related to exposure to carcinogens at work (Sixth individual Directive within the meaning of Article 16 (1) of Directive 89/391/EEC) EN Official Journal L 179 European Communities, 08/07/1997 pp. 0004-0006. 25 ACGIH, 2013. Threshold limit values and biological exposure indices. ACGIH, Cincinnati. www.acgih.org
24. Garte S, Popov T, Gergieva T et al. Biomarkers of exposure and effects in Bulgarian petrolchemical workers exposed to benzene. Chem Biol Interact 153-154, 247-251 (2005).
25. Schnatter AR, Glass DC, Tang G et al. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis J. Natl Cancer Inst. 104, 1724-1737 (2012).
26. Kim S, Vermeulen R, Waidyanatha S et al. Modeling human metabolism of benzene following occupational and environmental exposures. Cancer Epidemiol. Biomarkers Prev. 15(11), 2246-2252 (2006).
27. Kim S, Vermeulen R, Waidyanatha S et al. Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism. Carcinogenesis 7(4), 772-781 (2006).
28. Rappaport SM, Kim S, Thomas R, Johnson BA, Bois FY, Kupper LL. Low-dose metabolism of benzene in humans: science and obfuscation. Carcinogenesis. 34(1), 2-9 (2013).
29. Weisel CP, Park S, Pyo H, Mohan K, Witz G. Use of stable isotopically labeled benzene to evaluate environmental exposures. J. Expo. Anal. Environ. Epidemiol. 13(5), 393-402 (2003).
30. Rappaport SM, Waidyanatha S, Yeowell-O'Connell K et al. Protein adducts as biomarkers of human benzene metabolism. Chem. Biol. Interact. 153-154, 103-109 (2005).
31. Rappaport SM, Kim S, Lan Q et al. Evidence that humans metabolize benzene via two pathways. Environ. Health Perspect. 117(6), 946-952 (2009).
32. Rappaport SM, Kim S, Lan Q et al. Human benzene metabolism following occupational and environmental exposures. Chem. Biol. Interact. 184(1-2), 189-195 (2010).
33. Ghittori S, Fiorentino ML, Maestri L. Urinary excretion of unmetabolized benzene as an indicator of benzene exposure. J. Toxicol. Environ. Health. 38, 233-243 (1993).
34. Gaskel M, McLuckie KI, Farmer PB. Genotoxicity of the benzene metabolites para-benzoquinone and hydroquinone. Chem. Biol. Interact. 153-154, 267-270 (2005).
35. Dougherty D, Garte S, Barchowsky A, Zmuda J, Taioli E. NQO1, MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of benzene exposure a literature review. Tox. Lett. 82(1-3), 7-17 (2008).
36. Farmer PB, Kaur B, Roach J et al. The use of S-phenylmercapturic acid as a biomarker in molecular epidemiology studies of benzene. Chem. Biol. Interact. 153-154, 97-102 (2005).
37. Lovreglio P, Carrieri M, Barbieri A et al. Monitoring of the occupational and environmental exposure to low doses of benzene. G. Ital. Med. Lav. Ergon. 35(4), 251-255 (2013).
38. Boogaard PJ, Van Sitter NJ. Biological monitoring of exposure to benzene a comparison between s-phenylmercapturic acid, trans,trans-muconic acid, and phenol. Occup. Environ. Med. 52, 611-620 (1995).
39. Lovreglio P, Cancanelli G, Barbieri A et al. Influence of non-occupational sources on the levels of biomarkers of internal dose for use in biological monitoring of occupational exposure to extremely low concentrations of benzene. G. Ital. Med. Lav. Ergon. 32(1), 49-58 (2010).
40. Ruppert T, Scherer G, Tricker AR, Adlkofer F. trans,transmuconic acid as a biomarker of non-occupational environmental exposure to benzene. Int. Arch. Occup. Environ. Health. 69(4), 47-55 (1997).
41. Boogaard PJ, Van Sitter NJ. Suitability of s-phenylmercapturic acid and trans,trans-muconic acid as biomarker of exposure to low concentration of benzene. Environ Health Perspect. 104, 1151-1157 (1996).
42. Carrieri M, Bartolucci GB, Scapellato ML et al. Influence of glutathione S-transferases polymorphisms on biological monitoring of exposure to low doses of benzene. Tox Lett. 213(1), 63-68 (2012).
43. Lv BH, Song SZ, Zhang Z, Mei Y, Ye FL. Urinary S-phenylmercapturic acid as a key biomarker for measuring occupational exposure to low concentrations of benzene in Chinese workers: a pilot study J. Occup. Environ. Med. 56(3), 319-325 (2014).
44. Crebelli R, Tomei F, Zijno A et al. Exposure to benzene in urban workers: environmental and biological monitoring of traffic police in Rome. Occup. Environ. Med. 58(3), 165-171 (2001).
45. Lin LC, Chen WJ, Chiung YM, Shih TS, Liao PC. Association between GST genetic polymorphism and doserelated production of urinary benzene metabolite markers, trans, trans-muconic acid and S-phenylmercapturic acid. Cancer Epidemiol. Biomarkers Prev. 17(6), 1460-1469 (2008).
46. Manini P, De Palma G, Andreoli R et al. Occupational exposure to low levels of benzene: biomarkers of exposure and nucleic acid oxidation and their modulation by polymorphic xenobiotic metabolizing enzymes. Tox. Lett. 193(3), 229-235 (2010).
47. Mansi A, Bruni R, Capone P et al. Low occupational exposure to benzene in a petrochemical plant: modulating effect of genetic polymorphisms and smoking habit on the urinary t,t-MA/SPMA ratio. Tox. Lett. 213(1), 57-62 (2012).
48. De Palma G, Manno M. Metabolic polymorphisms and biomarkers of effect in the biomonitoring of occupational exposure to low-levels of benzene: state of the art. Tox. Lett. 231, 194-204 (2014).
49. Qu Q, Shore R, Li G et al. Biomarkers of benzene: urinary metabolites in relation to individual genotype and personal exposure. Chem. Biol. Interact. 153-154, 85-95 (2005).
50. Kim S, Lan Q, Waidyanatha S et al. Genetic polymorphisms and benzene metabolism in humans exposed to a wide range of air concentrations. Pharmacogenet. Genomics 17(10), 789-801 (2007).
51. Choi JY, Lee KM, Cho SH et al. CYP2E1 and NQO1 genotypes, smoking and bladder cancer. Pharmacogenetics 13, 349-355 (2003).
52. Verdina A, Galati R, Falasca G et al. Metabolic polymorphisms and urinary biomarkers in subjects with low benzene exposure. J. Toxicol. Environ. Health 64(8), 607-618 (2001).
53. Chanvaivit S, Navasumrit P, Hunsonti P, Autrup H, Ruchirawat M. Exposure assessment of benzene in Thai workers, DNA-repair capacity and influence of genetic polymorphisms. Mutat. Res. 626(1-2), 79-87 (2007).
54. Buthbumrung N, Mahidol C, Navasumrit P et al. Oxidative DNA damage and influence of genetic polymorphisms among urban and rural schoolchildren exposed to benzene. Chem. Biol. Interact. 172(3), 185-194 (2008).
55. Strange R, Jones P, Freyer A. Gluthatione S-transferase: genetics and role in toxicology. Tox. Lett. 112-113, 357-363 (2000).
56. Sorensen M, Poole J, Autrup H et al. Benzene exposure assessed by metabolite excretion in Estonian oil shale mineworkers: influence of glutathione s-transferase polymorphisms. Cancer Epidemiol. Biomarkers Prev. 13, 1729-1735 (2004).
57. Sorensen M, Skov H, Autrup H, Hertel O, Loft S. Urban benzene effects exposure andoxidative DNA damage: influence of genetic polymorphisms in metabolism genes. Sci. Total Environ. 309, 69-80 (2003).
58. Avogbe PH, Ayi-Fanou L, Autrup H et al. Ultrafine particolate matter and high-level benzene urban air pollution in relation to oxidative DNA damage. Carcinogenesis 26, 613-620 (2005).
59. Omiecinski CJ, Hassett C, Hosagrahara V. Epxoide hydrolase polymorphism and role in toxicology. Tox. Lett. 112-113, 365-370 (2000).
60. Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. NAD(P)H:quinone oxidoreductase1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphism. Chem. Biol. Interact. 129, 77-97 (2000).
61. Seigel D, McGuinness SM, Winski SL, Ross D. Genotype-phenotype relationships in studies of a polymorphisms in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics 9, 113-121 (1999).
62. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271(24), 14412-14420 (1996).
63. Dinkova-Kostova AT, Talalay P. NAD(P)H: quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch. Biochem. Biophys. 501, 116-123 (2010).
64. Ross D. Functions and distribution of NQO1 in human bone marrow: potential clues to benzene toxicity. Chem. Biol. Interact. 30(153-154), 137-146 (2005).
65. Hartwig A. The role of DNA repair in benzene-induced carcinogenesis. Chem. Biol. Interact. 184, 269-272 (2010).
66. Angelini S, Maffei F, Bermejo JL. Environmental exposure to benzene, micronucleus formation and polymorphisms in DNA-repair genes: a pilot study. Mutat. Res. 743, 99-104 (2012).
67. Xiao S, Gao L, Liu Y et al. Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population. Mut. Res. 751, 52-58 (2013).
68. Bagryantseva Y, Novotna B, Rossner P Jr et al. Oxidative damage to biological macromolecules in Prague bus drivers and garagemen: impact of air pollution and genetic polymorphisms. Toxicol. Lett. 199, 60-68 (2010).
69. Obe G, Pfeiffer P, Savage JR et al. Chromosomal aberrations: formation, identification and distribution. Mutat. Res. 504, 17-36 (2002).
70. Cogliano VJ, Baan R, Straif K. IARC Monographs programme staff. Updating IARC's carcinogenicity assessment of benzene. Am. J. Ind. Med 54(2), 165-167 (2011).
71. Baan R, Grosse Y, Straif K et al. A review of human carcinogens-Part F: chemical agents and related occupations. Lancet Oncol. 10(12), 1143-1144 (2009).
72. Khalade A, Jaakkola MS, Pukkala E, Jaakkola JJ. Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis. Environ. Health 9, 31 (2010).
73. Steinmaus C et al. Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup. Environ. Med. 65, 371-378 (2008).
74. Heck JE, Park AS, Qiu J, Cockburn M, Ritz B. Risk of leukemia in relation to exposure to ambient air toxics in pregnancy and early childhood. Int. J. Hyg. Environ. Health 217(6), 662-668 (2014).
75. Zhou Y, Zhang S, Li Z et al. Maternal benzene exposure during pregnancy and risk of childhood acute lymphoblastic leukemia: a meta-analysis of epidemiologic studies. PLoS ONE 9(10), e110466 (2014).
76. Kim SY, Choi JK, Cho YH et al. Chromosomal aberrations in workers exposed to low levels of benzene: association with genetic polymorphisms. Pharmacogenetics 14(7), 453-463 (2004).
77. Lindsey RH Jr, Bromberg KD, Felix CA, Osheroff N. 1,4-Benzoquinone is a topoisomerase II poison. Biochemistry 43(23), 7563-7574 (2004).
78. Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet. Med. 4(2), 62-70 (2002).
79. Infante-Rivard C, Vermunt JK, Weinberg CR. Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia. Am. J. Epidemiol. 165(11), 1248-1254 (2007).
80. Elhoseiny S, El-Wakil M, Fawzy M, Rahaman AA. GSTP1 (Ile105Val) gene polymorphism: risk and treatment response in chronic myeloid leukemia. J. Cancer Ther. 5, 1-10 (2014).
81. Krajinovic M, Labuda D, Sinnett D. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics 12(8), 655-658 (2002).
82. He HR, You HS, Sun JY et al. Glutathione S-transferase gene polymorphisms and susceptibility to acute myeloid leukemia: meta-analyses. Jpn. J. Clin. Oncol. 44(11), 1070-1081 (2014).
83. Karkukak M, Yakut T, Gulten T, Ali R. Investigation of GSTP1 (Ile105Val) gene polymorphism in chronic myeloid leukaemia patients. Int. J. Hum. Genet. 12(3), 145-149 (2012).
84. Ulusoy G, Adali O, Tumer TB, Sahin G, Gozdasoglu S, Arinç E. Significance of genetic polymorphisms at multiple loci of CYP2E1 in the risk of development of childhood acute lymphoblastic leukemia. Oncology 72(1-2), 125-131 (2007).
85. Vijayakrishnan J, Houlston RS. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 95(8), 1405-1414 (2010).
86. Wild CP. The exposome: from concept to utility. Int. J. Epidemiol. 41(1), 24-32 (2012).
87. Garte S, Gaspari L, Alexandrie AK et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10(12), 1239-1248 (2001).
88. Yang J, Bai W, Niu P, Tian L, Gao A. Aberrant hypomethylated STAT3 was identified as a biomarker of chronic benzene poisoning through integrating DNA methylation and mRNA expression data. Exp. Mol. Path. 96, 346-353 (2014).
89. Bai W, Chen Y, Yang J, Niu P, Tian L, Gao A. Aberrant miRNA profiles associated with chronic benzene poisoning. Exp. Mol. Path. 96, 426-430 (2014).
90. Xing C, Chen Q, Li G et al. Microsomal epoxide hydrolase (EPHX1) polymorphisms are associatedwith aberrant promoter methylation of ERCC3 and hematotoxicity in benzene-exposed workers. Environ. Mol. Mut. 54, 397-405 (2013).
91. Seow WJ, Pesatori AC, Dimont E et al. Urinary benzene biomarkers and DNA methylation in Bulgarian petrochemical workers: study findings and comparison of linear and beta regression models. PLoS ONE 7(12), e50471 (2012).
92. Hu J, Ma H, Zhang W, Yu Z, Sheng G, Fu J. Effects of benzene and its metabolites on global DNA methylation in human normal hepatic L02 cells. Environ. Toxicol. 29(1), 108-116 (2011).
93. Bollati V, Baccarelli A, Hou L et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 67, 876-880 (2007).
94. Baccarelli A, Wright R, Bollati V et al. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 21, 819-828 (2010).
95. Pearce MS, McConnell JC, Potter C et al. Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles. Int. J. Epidemiol. 41, 210-217 (2012).
96. Ji Z, Zhang L, Peng V et al. A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide. Leukemia 24(5), 986-991 (2010).
97. Kuang SQ, Tong WG, Yang H et al. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia 22(8), 1529-1538 (2008).
98. Greiner J, Ringhoffer M, Simikopinko O et al. Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Exp. Hematol. 28(12), 1413-1422 (2000).
99. Galm O, Herman JG, Baylin SB. The fundamental role of epigenetics in hemapotoietic malignacies. Blood Rev. 20, 1-13 (2006).
100. Li P, Harris D, Liu Z, Liu J, Keating M, Estrov Z. Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells. PLoS ONE 5(7), e11859 (2010).
101. Omer A, Yadav NK, Singh P, Singh RK. Hematological malignancies: role of miRNAs and their in silico aspects. Expert Rev. Anticancer Ther. 13, 1121-1133 (2013).
102. Angelini S, Kumar R, Bermejo JL et al. Exposure to low environmental levels of benzene: evaluation of micronucleus frequencies and S-phenylmercapturic acid excretion in relation to polymorphisms in genes encoding metabolic enzymes. Mutat. Res. 719(1-2), 7-13 (2011).
103. Li D, Dandara C, Parker MI. Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus. Clin. Chem. Lab. Med. 43(4), 370-375 (2005).
104. Lakhdar R, Denden S, Mouhamed MH et al. Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease. Exp. Lung Res. 37, 195-204 (2011).
105. Takeyabu K, Yamaguchi E, Suzuki I, Nishimura M, Hizawa N, Kamakam Y. Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population. Eur. Respir. J. 15, 891-894 (2000).
106. Xu LL, Liu G, Miller DP et al. Counterpoint: the myeloperoxidase-463G a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol. Biomarkers Prev. 11, 1555-1559 (2002).
107. Ying Li Y, Qin Y, Wang ML, Zhu HF, Huang XE. The myeloperoxidase-463 G> a polymorphism influences risk of colorectal cancer in Southern China: a case-control study. Asian Pac. J. Cancer Prev. 12, 1789-1793 (2011).
108. Guo S, Gao M, Li X et al. Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PLoS ONE 7(10), e47939 (2012).